Table 1 Baseline Characteristics in Clinical Papers: P-Values vs SMD and Summary Statistics
When reviewers critique your clinical manuscript's baseline characteristics table, formatting errors often stem from mismatched summary statistics, silent missingness, or improper p-values. Here is how to format Table 1 for RCTs and observational cohorts under CONSORT and STROBE guidelines.
HumanPen Team
· 11 min read
How to format Table 1 baseline characteristics in clinical manuscripts
To format Table 1 correctly in clinical manuscripts, report mean ± standard deviation for symmetric continuous variables, median with interquartile range for skewed distributions, and frequencies with percentages for categorical factors. In randomized controlled trials (RCTs), CONSORT Item 15 explicitly discourages baseline significance p-values because randomization ensures differences arise by chance. In observational cohort studies, report Standardized Mean Differences (SMD) alongside per-variable missingness under STROBE Item 14 to assess covariate balance across treatment arms.
Clinical investigators, biostatisticians, and medical postgraduates frequently stumble when assembling Table 1 for peer review. Editors and statistical reviewers at flagship clinical journals routinely issue major revisions when authors paste mismatched denominators into Microsoft Word, hide substantial variable missingness, or decorate randomized trial baselines with asterisks denoting statistical significance. Meeting reporting standards requires aligning table typography with modern epidemiological guidelines, connecting the study design directly to CONSORT clinical trial reporting standards and structuring medical abstracts under ICMJE rules.
Baseline significance tests in randomized trials evaluate a null hypothesis known to be true, while in observational cohorts p-values confound sample size with clinical covariate imbalance; use SMD instead.
Why CONSORT Item 15 discourages baseline p-values in RCTs—and when cohorts require SMD
CONSORT 2010 Item 15 explicitly states that significance tests of baseline differences in randomized controlled trials should not be performed. The fundamental rationale rests on probability theory: when patients are assigned through genuine random allocation, the null hypothesis of no difference between study groups is known a priori to be true. Any observed difference in age, blood pressure, or biomarker level is, by definition, a consequence of random sampling fluctuation rather than systematic bias. Reporting p-values under these conditions is scientifically illogical, as a statistically significant finding (`p < 0.05`) merely represents an expected Type I error (false positive) inherent in testing multiple baseline parameters.
In non-randomized observational cohort and case-control studies, the methodological dilemma is reversed. Confounding by indication and selection bias mean true systematic baseline differences do exist. However, relying on hypothesis test p-values (such as student t-tests or chi-square tests) to evaluate balance remains flawed because p-values are heavily driven by sample size. In a nationwide registry of 80,000 patients, a clinically meaningless difference of 0.2 years in mean age will yield `p < 0.001`, causing researchers to over-adjust. Conversely, in a pilot cohort of 60 patients, a large, confounding clinical difference in baseline renal failure might yield `p = 0.18`, misleading authors into assuming balance.
| Dimension | Randomized Controlled Trial (RCT) | Observational Cohort Study | Propensity Score Matched Cohort |
|---|---|---|---|
| Reporting Guideline | CONSORT Statement (Item 15) | STROBE Statement (Item 14) | STROBE & Propensity Score Guidelines |
| Group Comparison Hypothesis | Null hypothesis known true by randomization | True systematic confounding expected | Aims to mimic randomized balance |
| P-value Inclusion | Discouraged by CONSORT and editors | Discouraged (sample size dependent) | Strictly discouraged (pairs matched) |
| Primary Balance Metric | Clinical judgment of prognostic factors | Standardized Mean Difference (SMD) | Standardized Mean Difference (SMD) |
| Acceptable Balance Threshold | Prognostic covariate distribution check | SMD < 0.10 indicates negligible imbalance | SMD < 0.10 across all matched covariates |
| Per-Variable Missingness | Report counts missing per randomized arm | Mandatory per-variable missing counts | Report missingness pre- and post-matching |
To resolve the sample size confounding of p-values, epidemiological methodology relies on the Standardized Mean Difference (SMD). SMD calculates the difference in means between two groups divided by the pooled standard deviation, making it independent of sample size. For continuous variables, it reflects Cohen's d framework, while for categorical variables, it aggregates multi-category probability discrepancies into a Mahalanobis distance metric. Methodological literature establishes clear interpretation standards: an `SMD < 0.10` represents ideal covariate balance; an `SMD` between 0.10 and 0.20 indicates acceptable residual difference; and an `SMD >= 0.20` flags substantial baseline imbalance requiring multivariable regression adjustment, propensity score weighting, or instrumental variable methods.
Unlike p-values that shrink toward zero as sample size grows, SMD measures the pure magnitude of baseline covariate disparity; aim for SMD values under 0.10 across all primary prognostic factors.
Selecting summary statistics, normality diagnostics, and reporting missingness
Selecting the appropriate summary statistics for continuous variables in Table 1 requires rigorous distributional evaluation rather than default assumptions. For normally distributed parameters, report the sample mean and standard deviation (`mean ± SD`). For skewed variables—such as hospital length of stay, serum troponin, or intensive care unit costs—authors must report the median and interquartile range (`median [IQR]`), explicitly defining whether the brackets convey the 25th and 75th percentiles (e.g., `52 [38, 71]`) or the interquartile distance. Importantly, authors must never report standard error of the mean (SEM) in Table 1; SEM describes the uncertainty of estimating a population mean across hypothetical repeated samples, whereas Table 1 is designed to describe the biological variability of the specific study cohort.
For categorical and binary variables, authors should report both frequencies and percentages as `n (%)`. When presenting percentages, verify that the calculation denominator is clearly identified. In tables with baseline columns for Total, Control, and Intervention, percentage figures within each treatment column should use that specific column's participant total as the denominator (column percentages), allowing direct comparison of prevalence across study arms. If small cell counts occur in observational cohorts where hypothesis tests are calculated, verify whether expected frequencies drop below 5; Fisher's exact test should replace Pearson's chi-square test to avoid inaccurate p-value approximations.
- Verify continuous distributions using Shapiro-Wilk tests, skewness coefficients, and Q-Q visual inspection, assigning `mean ± SD` to symmetric variables and `median [IQR]` to skewed variables.
- Present categorical variables with absolute counts and column-wise percentages, ensuring percentages within each category sum to 100% of the non-missing total.
- Comply with STROBE Item 14 by adding an explicit `Missing, n (%)` row or a dedicated missing column for every variable with incomplete registry records.
- Define all statistical symbols and abbreviations (`SD`, `IQR`, `SMD`, `BMI`) in the table footnote, stating the software package and distribution thresholds utilized.
Reporting missing data represents a critical compliance benchmark under STROBE Item 14. Observational cohorts derived from electronic health records frequently suffer from incomplete laboratory tests, unrecorded smoking statuses, or missing socio-economic indicators. Suppressing missing counts and reporting summary statistics only for available cases without disclosure distorts table denominators. A reviewer observing a cohort of 1,500 patients where the blood biomarker row quietly reflects only 920 records will suspect undisclosed attrition. Authors must transparently display the number of missing values per variable, either in an adjacent column or as a distinct nested row, enabling readers to assess whether missingness is completely at random or introduces selection bias.
Automating Table 1 generation from CSV or Excel data using tableone
Assembling Table 1 manually by copying numbers from statistical software output into Microsoft Word or Excel cells is prone to error. In clinical trials and prospective cohorts, patient datasets undergo frequent revisions during the peer-review cycle: secondary data cleaning might exclude 15 patients with protocol violations, or a reviewer might request excluding patients with prior cardiovascular events. When inclusion criteria shift, recalculating twenty continuous variables and thirty categorical levels by hand leads to mismatched denominators, typographical transcription slips, and desynchronized cell alignments across manuscript drafts.
To eliminate manual transcription errors and ensure reproducible table generation, biostatisticians rely on automated tools such as the open-source Python `tableone` package developed by Pollard et al. (2018, JAMIA Open)—inspired by Kazuki Yoshida and Justin Bohn's CRAN R `tableone` package. The package directly ingests structured patient dataframes, allowing analysts to configure lists of continuous variables, categorical factors, and stratification groups in reproducible scripts. By passing parameters such as `nonnormal` for skewed continuous metrics and specifying `smd=True`, `tableone` automatically calculates distribution-appropriate statistics, computes standardized mean differences across comparison arms, and outputs formatted summary strings in a single execution.
A robust computational pipeline links clean data to formatted deliverables. For instance, reading `data/patient_registry.csv` via Python's pandas library, an investigator defines `columns = ['age', 'systolic_bp', 'creatinine', 'diabetes_status']`, designates `categorical = ['diabetes_status']`, and sets `groupby = 'treatment_arm'`. Calling `TableOne(df, columns=columns, categorical=categorical, groupby=groupby, nonnormal=['creatinine'], smd=True, pval=False)` generates the complete baseline matrix. The resulting table object can be exported directly to a styled Microsoft Word `.docx` three-line table via `python-docx` or R `flextable`, establishing an audit trail where cell values in table cell `B2` or `C15` link directly to underlying raw records.
Scripting Table 1 through tableone converts hours of vulnerable manual transcription into an automated script that updates across thirty clinical variables in seconds whenever inclusion criteria shift.
Streamlining baseline table production with reproducible workflows in HumanPen
Managing complex clinical data transformations, formatting custom three-line tables for medical journals, and documenting reproducible code scripts can be orchestrated end-to-end within HumanPen Start Project. Attach your data and papers, describe what you need, approve the plan before work starts, and get the reviewed report, charts, and code ready to preview online or download.
This reproducible workflow is demonstrated in the public International Stroke Trial (IST) secondary analysis project live on the platform (explore the IST public project). Analyzing raw patient data from 19,435 randomized patients across a 3×2 factorial design evaluating aspirin and subcutaneous heparin, the platform reproduced the 1997 Lancet event counts (62.2% vs 63.5% 6-month death or dependency; unadjusted `p = 0.072`, prespecified covariate-adjusted odds ratio `OR = 0.93`, `95% CI 0.87–0.99`). The deliverable includes a 37-page `SAR.docx` containing 22 publication-grade tables—including complete Table 1 baseline clinical characteristics—paired with automated Python scripts and an independent R cross-check script (`check_with_R.R`).
Researchers can upload datasets and protocols in Excel, CSV, Word, PDF, or zip archives up to 2 GB. Statistical calculations run in an isolated computing sandbox using Python or R; analyses originally planned in SPSS or Stata are executed using modern Python or R equivalents. Data from external proprietary databases such as CNKI or Wind must be exported locally before uploading, and GPU training is not supported. Importantly, all delivered tables, statistical reports, and scripts serve as an audited methodological and learning reference draft. The principal investigator, clinical fellow, or biostatistician remains responsible for verifying every cell count against hospital source records, supplying institutional disclosures, and ensuring adherence to journal authorship and research ethics standards.
Every project runs in an isolated sandbox encrypted in transit, undergoes two-stage plan confirmation, maintains version history across revisions, and is retained for 6 months with anytime manual deletion.
Frequently asked questions
Should I report mean (SD) or median (IQR) if a continuous variable is only slightly skewed? If a clinical parameter displays mild skewness where the mean and median diverge moderately, best practice depends on clinical interpretability and literature precedent. If the skewness coefficient falls between -0.5 and +0.5, reporting `mean ± SD` is generally accepted by medical editors, particularly if historical benchmark trials reported means. However, if the biological variable contains a hard physical floor (such as laboratory values bounded at zero like serum bilirubin) or exhibits outliers that artificially stretch the standard deviation beyond the mean, `median [IQR]` is strongly preferred to prevent impossible negative confidence intervals.
What should I do if a clinical journal peer reviewer insists on adding p-values to an RCT Table 1? If a reviewer requests baseline p-values for a randomized trial, cite CONSORT 2010 Item 15 in your response letter. Explain politely that because genuine randomization was conducted, the null hypothesis is true by design and statistical tests merely test the random allocation process itself. Emphasize that reporting p-values in baseline tables can mislead readers into interpreting random baseline variations as systematic bias. If the editor insists on inclusion as a mandatory house style, compute the p-values but add an explicit footnote stating that all baseline tests reflect random allocation fluctuation under CONSORT guidelines.
How is the Standardized Mean Difference (SMD) calculated for multi-category nominal variables? For multi-category nominal variables (such as cancer staging or race/ethnicity with four levels), SMD cannot be computed using a simple two-group difference formula. Instead, biostatisticians use the multivariate generalization described by Austin and Stuart, which calculates a Mahalanobis distance across the vector of category proportions against the pooled covariance matrix. In open-source packages such as `tableone`, setting `smd=True` automatically performs this multi-category covariance calculation, generating a single summary SMD value that reflects the aggregate distributional balance across all categories simultaneously.
What is the difference between standard deviation (SD) and standard error (SE), and why is SE forbidden in Table 1? Standard deviation (SD) quantifies the biological dispersion of individual patient observations within your sample around their mean. Standard error of the mean (SE, calculated as `SD / sqrt(n)`), by contrast, measures the statistical precision of the sample mean as an estimate of the true population mean. Because `sqrt(n)` grows with sample size, SE is always substantially smaller than SD. Some authors mistakenly report `mean ± SE` to make their data appear less variable, but Table 1 is intended to inform clinicians about the actual patient case-mix in the study, making SD mandatory and SE misleading.
Sources and reporting guidelines
- EQUATOR Network — STROBE Reporting Guideline for Observational Studies — STROBE guidelines for reporting observational cohort, case-control, and cross-sectional studies in medical research (Item 14 demographic and clinical baseline characteristics).
- tableone Python Package Documentation — Creating 'Table 1' for Biomedical Research — Technical documentation for the open-source library automating summary statistics, distribution-specific metrics, and standardized mean differences.
- Pollard et al. (2018, JAMIA Open) — tableone: An Open Source Python Package for Producing Summary Statistics — Pollard TJ, Johnson AEW, Raffa JD, Mark RG. tableone: an open source Python package for producing summary statistics for research papers. JAMIA Open. 2018;1(1):26–31.
Primary-source guidelines and package documentation verified via live HTTP retrieval on November 18, 2026. Consult individual target journal guidelines and editorial instructions for specific three-line table typography, symbol definitions, and footnote formatting rules.
KEEP READING
Regression Discontinuity Design RDD Checklist: rdrobust Bandwidth, Manipulation Tests & RD Plots
11 min read
Academic writingHow to Report Kaplan-Meier Curves, Numbers at Risk, and Cox Regression in Medical Journals
12 min read
Academic writingSystematic Review & Meta-Analysis: PRISMA 2020 & Forest Plots
11 min read